Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
3.050
-0.640 (-17.34%)
At close: Dec 5, 2025, 4:00 PM EST
3.140
+0.090 (2.95%)
After-hours: Dec 5, 2025, 8:00 PM EST
Picard Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 4.77 | 4.39 | 5.04 | 4.11 |
| Revenue Growth (YoY) | 8.81% | -12.93% | 22.61% | - |
| Cost of Revenue | 5.25 | 4.5 | 7.35 | 9.1 |
| Gross Profit | -0.48 | -0.11 | -2.31 | -4.99 |
| Selling, General & Admin | 10.06 | 10.22 | 10.98 | 4.18 |
| Research & Development | 3.29 | 3.38 | 2.21 | 1.9 |
| Operating Expenses | 13.35 | 13.6 | 13.19 | 6.08 |
| Operating Income | -13.83 | -13.71 | -15.5 | -11.07 |
| Interest Expense | -6.82 | -3.07 | -0.14 | -0.01 |
| Interest & Investment Income | - | - | 0 | 0.01 |
| Other Non Operating Income (Expenses) | -10.89 | -4.29 | 0.07 | -0.09 |
| Pretax Income | -31.53 | -21.07 | -15.57 | -11.16 |
| Income Tax Expense | 0.02 | -0.02 | -0 | 0.01 |
| Net Income | -31.55 | -21.06 | -15.57 | -11.17 |
| Preferred Dividends & Other Adjustments | 0.67 | 2.68 | 2.43 | 1.5 |
| Net Income to Common | -32.22 | -23.74 | -18 | -12.67 |
| Shares Outstanding (Basic) | 20 | 8 | 8 | 6 |
| Shares Outstanding (Diluted) | 20 | 8 | 8 | 6 |
| Shares Change (YoY) | 149.19% | - | 42.07% | - |
| EPS (Basic) | -1.63 | -2.99 | -2.27 | -2.27 |
| EPS (Diluted) | -1.63 | -2.99 | -2.27 | -2.27 |
| Free Cash Flow | -14.45 | -11.87 | -10.64 | -10.75 |
| Free Cash Flow Per Share | -0.73 | -1.50 | -1.34 | -1.92 |
| Gross Margin | -10.05% | -2.55% | -45.83% | -121.27% |
| Operating Margin | -290.04% | -312.27% | -307.40% | -269.07% |
| Profit Margin | -675.90% | -540.58% | -356.97% | -308.05% |
| Free Cash Flow Margin | -303.08% | -270.42% | -211.01% | -261.42% |
| EBITDA | -13.66 | -13.49 | -14.92 | -10.52 |
| EBITDA Margin | -286.57% | - | -295.80% | -255.82% |
| D&A For EBITDA | 0.17 | 0.23 | 0.59 | 0.55 |
| EBIT | -13.83 | -13.71 | -15.5 | -11.07 |
| EBIT Margin | -290.04% | - | - | -269.07% |
| Revenue as Reported | 4.77 | 4.39 | 5.04 | 4.11 |
Source: S&P Capital IQ. Standard template.
Financial Sources.